Your browser doesn't support javascript.
loading
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.
Keek, Simon A; Kayan, Esma; Chatterjee, Avishek; Belderbos, José S A; Bootsma, Gerben; van den Borne, Ben; Dingemans, Anne-Marie C; Gietema, Hester A; Groen, Harry J M; Herder, Judith; Pitz, Cordula; Praag, John; De Ruysscher, Dirk; Schoenmaekers, Janna; Smit, Hans J M; Stigt, Jos; Westenend, Marcel; Zeng, Haiyan; Woodruff, Henry C; Lambin, Philippe; Hendriks, Lizza.
Afiliación
  • Keek SA; The D-Lab, Department of Precision Medicine, GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Kayan E; The D-Lab, Department of Precision Medicine, GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Chatterjee A; The D-Lab, Department of Precision Medicine, GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Belderbos JSA; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bootsma G; Department of Pulmonary Diseases, Zuyderland Hospital, Heerlen, The Netherlands.
  • van den Borne B; Department of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands.
  • Dingemans AC; Department of Pulmonary Diseases, Erasmus MC, Rotterdam, The Netherlands.
  • Gietema HA; Department of Radiology and Nuclear Medicine, GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Groen HJM; Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Herder J; Department of Pulmonary Diseases, Meander Medical Center, Amersfoort, The Netherlands.
  • Pitz C; Department of Pulmonary Diseases, Laurentius Hospital, Roermond, The Netherlands.
  • Praag J; Department of Radiotherapy, Erasmus MC, Rotterdam, The Netherlands.
  • De Ruysscher D; Department of Radiation Oncology (Maastro), GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Schoenmaekers J; Department of Pulmonary Diseases, GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Smit HJM; Department of Pulmonary Diseases, Rijnstate, Arnhem, The Netherlands.
  • Stigt J; Department of Pulmonary Diseases, Isala Hospital, Zwolle, The Netherlands.
  • Westenend M; Department of Pulmonary Diseases, VieCuri, Venlo, The Netherlands.
  • Zeng H; Department of Radiation Oncology (Maastro), GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Woodruff HC; The D-Lab, Department of Precision Medicine, GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Lambin P; The D-Lab, Department of Precision Medicine, GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Hendriks L; Department of Pulmonary Diseases, GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
Ther Adv Med Oncol ; 14: 17588359221116605, 2022.
Article en En | MEDLINE | ID: mdl-36032350
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos